The different distribution patterns of FDG and FDG-labelled WBC in inflammatory and infectious lesions

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 10, 2012, Pages 1660-1661

  Yılmaz, Sabire ^a   Ocak, Meltem ^b   Asa, Sertac ^a   Aliyev, Anar ^a   Ozhan, Meftune ^a   Halac, Metin ^a   Sager, Sait ^a   Kabasakal, Levent ^a   Sonmezoglu, Kerim ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868191822     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-012-2170-4     Document Type: Note

References (4)

1. Osman S, Danpure HJ. The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography. Int J Rad Appl Instrum B 1992;19:183-90.
2. Pellegrino D, Bonab AA, Dragotakes SC, Pitman JT, Mariani G, Carter EA. Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG. J Nucl Med 2005;46:1522-30.
3. Pio BS, Byrne FR, Aranda R, Boulay G, Spicher K, Song MH, et al. Noninvasive quantification of bowel inflammation through positron emission tomography imaging of 2-deoxy-2-[18F]fluoro-D-glucose-labeled white blood cells. Mol Imaging Biol 2003;5:271-7.
4. Dumarey N, Egrise D, Blocklet D, Stallenberg B, Remmelink M, del Marmol V, et al. Imaging infection with 18F-FDGlabeled leukocyte PET/CT: initial experience in 21 patients. J Nucl Med 2006;47:625-32.